Enzymotec Ltd (NASDAQ:ENZY)

8.87
Delayed Data
As of May 01
 -0.19 / -2.10%
Today’s Change
5.38
Today|||52-Week Range
20.74
+16.10%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close9.06
Today’s open9.05
Day’s range8.81 - 9.06
Volume11,935
Average volume (3 months)72,005
Market cap$199.5M
Dividend yield--
Data as of 3:59pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-76.16%
Earnings growth (this year)-19.12%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)-27.51%
P/E ratio--
Price/Sales3.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...-0.02-0.91%
PSTIPluristem Therapeuti...+0.08+3.02%
NDRMNeuroderm Ltd+0.42+3.60%
CYTRCytRx Corp-0.69-15.72%
Data as of 4:01pm ET, 05/01/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.06
Annual revenue (last year)$47.1M
Annual profit (last year)$7.8M
Net profit margin16.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Operations Officer
Yoni Twito
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers